S-RALP(N = 151) | L-RALP(N = 126) | P value | |
---|---|---|---|
Biochemical recurrence, no. (%) | 17(11.2%) | 19(15.1%) | 0.348 |
Time to Biochemical recurrence, (w) | 24(4–36)w | 36(8–60)w | 0.825 |
Adjuvant therapy, no. (%) | 33(21.9%) | 27(21.4%) | 0.932 |
Continence at follow-up, no (%) | |||
0-Pad | 119(78.8%) | 112(88.9%) | 0.025 |
0–1 safety Pad | 138(91.4%) | 119(94.4%) | 0.330 |
Time to continence (d), median (IQR) | |||
0-Pad | 7 (2–52)w | 2(1–39)w | < 0.001 |
0–1 safety Pad | 6.5(2–45)w | 2(1–29)w | < 0.001 |